Business registries · firm from USPTO records
Celgene Corporation
USPTO only Derived from USPTO records only (patent assignees and trademark owners); FURP found no state registration, Form D, Form ADV, nonprofit, SEC or lobbying record with this name and place.
- Place
- 86 Morris Avenue, Summit, NJ
- Entity type
- Corporation
- State of organization
- DE (as the owner states it in trademark filings)
- Patents
- 402 granted 1997-01-21 to 2025-12-30
- Trademarks
- 630, 233 live
- Record
- EXACT high confidence: USPTO records only: patent assignee and trademark owner with the same name (legal endings aside) and place
- Source
- USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12734170 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | 2026-09-15 | PTBLXML, file of 2026-09-15 |
| US 12715869 | Modulators of CAMKK2 as ligand directed degraders | 2026-08-25 | PTBLXML, file of 2026-08-25 |
| US RE50917 | Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 2026-06-16 | PTBLXML, file of 2026-06-16 |
| US 12624003 | Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases | 2026-05-12 | PTBLXML, file of 2026-05-12 |
| US 12605372 | Combination therapy for the treatment of cancer | 2026-04-21 | PTBLXML, file of 2026-04-21 |
| US 12590953 | Methods for screening cereblon modifying compounds | 2026-03-31 | PTBLXML, file of 2026-03-31 |
| US 12583837 | Solid forms comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and salts thereof, and compositions comprising and methods of using the same | 2026-03-24 | PTBLXML, file of 2026-03-24 |
| US 12577223 | Processes for preparing 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | 2026-03-17 | PTBLXML, file of 2026-03-17 |
| US 12552771 | Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases | 2026-02-17 | PTBLXML, file of 2026-02-17 |
| US 12545740 | Engineering of an antibody for tumor-selective binding of CD47 | 2026-02-10 | PTBLXML, file of 2026-02-10 |
| US 12510533 | Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile | 2025-12-30 | PVGPATDIS, file of 2026-04-10 |
| US 12486281 | Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith | 2025-12-02 | PVGPATDIS, file of 2026-04-10 |
| US 12474342 | Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies | 2025-11-18 | PVGPATDIS, file of 2026-04-10 |
| US 12472176 | Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same | 2025-11-18 | PVGPATDIS, file of 2026-04-10 |
| US 12435028 | Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate | 2025-10-07 | PVGPATDIS, file of 2026-04-10 |
| US 12428488 | Engineering of an antibody for tumor-selective binding of CD47 | 2025-09-30 | PVGPATDIS, file of 2026-04-10 |
| US 12410133 | Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof | 2025-09-09 | PVGPATDIS, file of 2026-04-10 |
| US 12404241 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | 2025-09-02 | PVGPATDIS, file of 2026-04-10 |
| US 12404239 | Modulators of BCL6 as ligand directed degraders | 2025-09-02 | PVGPATDIS, file of 2026-04-10 |
| US 12400737 | Methods of classifying diffuse large B-cell lymphoma | 2025-08-26 | PVGPATDIS, file of 2026-04-10 |
| US 12396995 | Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use | 2025-08-26 | PVGPATDIS, file of 2026-04-10 |
| US 12391672 | Solid forms comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same | 2025-08-19 | PVGPATDIS, file of 2026-04-10 |
| US 12357633 | Methods of treating cancer by targeting cold tumors | 2025-07-15 | PVGPATDIS, file of 2026-04-10 |
| US 12343346 | Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same | 2025-07-01 | PVGPATDIS, file of 2026-04-10 |
| US 12338235 | Heterocyclic compounds and their use for treatment of helminthic infections and diseases | 2025-06-24 | PVGPATDIS, file of 2026-04-10 |
The newest 25 of 402. All patents of this assignee
Trademarks
| Mark | Serial | Filed | Status | Classes | Source |
|---|---|---|---|---|---|
| AMZYART | 99872237 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-20 |
| ARDEGVI | 99872234 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-20 |
| ARMARXI | 99872232 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-20 |
| ARTREYVO | 99872226 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-20 |
| ARXELDUA | 99872223 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-20 |
| ARZODUA | 99872219 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-18 |
| DEGARVI | 99872213 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-18 |
| DEYDESGO | 99872207 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-18 |
| XEBRYAR | 99871344 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-18 |
| VOZDEGRA | 99871339 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-18 |
| TREVRAYO | 99871338 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-18 |
| REYXARGO | 99871333 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-18 |
| ORDEGRIA | 99871329 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-18 |
| ONZARVIQ | 99871326 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-18 |
| ONXARVIQ | 99871321 | 2026-06-08 | Pending application | 005 | TRTDXFAP, file of 2026-10-18 |
| DEGLIBAR | 99802863 | 2026-05-04 | Pending application | 005 | TRTDXFAP, file of 2026-10-07 |
| DEZARQLI | 99802861 | 2026-05-04 | Pending application | 005 | TRTDXFAP, file of 2026-10-07 |
| ARVREYZO | 99802860 | 2026-05-04 | Pending application | 005 | TRTDXFAP, file of 2026-10-07 |
| XEYDEGRO | 99802857 | 2026-05-04 | Pending application | 005 | TRTDXFAP, file of 2026-10-07 |
| ONXARLIS | 99802849 | 2026-05-04 | Pending application | 005 | TRTDXFAP, file of 2026-10-07 |
| ARXELBRO | 99802846 | 2026-05-04 | Pending application | 005 | TRTDXFAP, file of 2026-10-07 |
| ZEMDEZOS | 99802843 | 2026-05-04 | Pending application | 005 | TRTDXFAP, file of 2026-10-07 |
| ARDULEON | 99802841 | 2026-05-04 | Pending application | 005 | TRTDXFAP, file of 2026-09-15 |
| ONXELDAR | 99802839 | 2026-05-04 | Pending application | 005 | TRTDXFAP, file of 2026-10-07 |
| ARXELDU | 99802836 | 2026-05-04 | Pending application | 005 | TRTDXFAP, file of 2026-10-07 |
The newest 25 of 630. All marks of this owner
Possible related entities
- ABRAXIS BIOSCIENCE, LLC firm from USPTO records, 22 patents, 11 trademarks FUZZY same street address (trademark filings)
- Avila Therapeutics, Inc. firm from USPTO records, 2 trademarks FUZZY same street address (trademark filings)
- Celgene Corporatin firm from USPTO records, 1 trademarks FUZZY same street address (trademark filings)
- Celgene Corporatoin firm from USPTO records, 2 trademarks FUZZY same street address (trademark filings)
- CNA Holdings Inc. firm from USPTO records, 4 trademarks FUZZY same street address (trademark filings)
- Impact Biomedicines, Inc. firm from USPTO records, 2 patents, 6 trademarks FUZZY same street address (trademark filings)
- Juno Therapeutics, Inc. firm from USPTO records, 3 trademarks FUZZY same street address (trademark filings)
Sharing an address can mean a parent and subsidiary, a shared office or a registered agent; it isn’t proof of a connection.
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.